GlassScriptPhysician profile
Lindsey Syed
NPI 1942756374
$1,022.51
in general payments reported to CMS, 2019-2025
18 companies · $216 in 2025
The $216 reported for 2025 was more than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $336 · 2022: $60.30 · 2023: $258 · 2024: $152 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $625.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $260.98 | 2021-2025 | |
| Glaxosmithkline, LLC. | $101.10 | 2023 | Jemperli |
| Caldera Medical, INC | $92.97 | 2021 | |
| Coopersurgical, INC. | $78.46 | 2023-2025 | Paragard T 380a, Paragard T 380a |
| Avion Pharmaceuticals | $63.96 | 2021 | |
| Exeltis, USA INC. | $60.09 | 2024-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $58.95 | 2025 | |
| Sumitomo Pharma America, INC. | $42.79 | 2023 | Myfembree |
| Organon LLC | $35.79 | 2021-2024 | |
| Astellas Pharma US INC | $32.94 | 2025 | Veozah |
| Astrazeneca Pharmaceuticals LP | $32.12 | 2023 | |
| Merck Sharp & Dohme LLC | $31.15 | 2023 | Keytruda, Lynparza |
| Hologic Sales and Service, LLC | $25.93 | 2025 | Aptima |
| Millicent US INC | $23.81 | 2025 | Femlyv, Intrarosa |
| Aspira Women'S Health INC | $22.92 | 2024 | Ova1 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $21.87 | 2022 | |
| Agile Therapeutics, INC. | $21.49 | 2024 | Twirla |
| Lupin INC. | $15.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Syed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.